In the literature, the estimated sensitivity of serum CEA for detecting relapsed disease in patients with completely resected CRC is 58%–89%, with a 1.5–6.0-month lead time between serum CEA level elevation and recurrence detection [26–29]. This evidence concerns the gene CEACAM5 and colorectal carcinoma.